| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 1.9K | 3.2% | 0.9% |
| Total Income | 1.9K | 3.2% | 0.9% |
| Expenditure | 1.7K | 4.6% | 6.4% |
| PBT | 175.00 | 9.8% | 32.4% |
| Net Profit | 114.00 | 19.7% | 41.8% |
| OPM | 10.16% | 1.17pp | 4.62pp |
| NPM | 6.16% | 1.76pp | 4.53pp |
| EPS | 1.80 | 20.0% | 40.8% |
Ingredion Reports Q2 2026 Results, Reaffirms Full-Year Guidance Amidst Tate & Lyle Acquisition Progress
04 Aug 2026 · 4 Aug, 3:41 pm
Summary
Ingredion Incorporated reported second quarter 2026 results with net sales increasing 1% to $1.85 billion, driven by volume growth in Texture & Healthful Solutions and favorable foreign exchange in LATAM. However, reported operating income decreased 31% to $188 million and reported diluted EPS fell to $1.78 from $2.99 in the prior year quarter. The company is reaffirming its full-year 2026 guidance, which has been amended to reflect the sale of its Pakistan business. Management highlighted progress on the pending acquisition of Tate & Lyle, with shareholders approving the offer.
Key Highlights
- 1
Second quarter 2026 reported operating income decreased 31% to $188 million compared to the second quarter 2025.
- 2
Second quarter 2026 reported diluted EPS were $1.78, compared with $2.99 in the second quarter 2025.
- 3
Second quarter net sales increased 1% to $1.85 billion, driven by higher net sales volume in Texture & Healthful Solutions and favorable foreign exchange in Food & Industrial Ingredients–LATAM.
- 4
Texture & Healthful Solutions delivered its ninth consecutive quarter of broad-based net sales volume growth.
- 5
Ingredion is reaffirming its amended full-year 2026 guidance, which now reflects the sale of a majority stake in the Pakistan business.
- 6
Tate & Lyle's shareholders approved Ingredion's all-cash offer, marking an important step toward completing the transaction.
Management Comments
Jim Zallie
Ingredion delivered a solid second quarter, with Texture & Healthful Solutions continuing its quarterly net sales volume growth and Food & Industrial Ingredients—U.S./CAN operating results sequentially improving during the quarter. Additionally, we completed the sale of our majority stake in the Pakistan business, and we are pleased to report that Tate & Lyle’s shareholders approved our recommended all-cash offer on July 28, marking an important step toward completing the transaction. Texture & Healthful Solutions delivered its ninth consecutive quarter of broad-based net sales volume growth, driven by continued strong customer demand for our solutions offerings, including clean-label ingredients, demonstrating the durability and margin enhancement of our solutions-selling model. Food & Industrial Ingredients–LATAM continued to deliver in line with expectations, which was a result of focused execution across the region, the resilience of our diversified businesses, and the advancement of network optimization opportunities, which included the announced closure of our Cabo, Brazil facility. We also successfully navigated foreign exchange headwinds and macroeconomic pressures. In Food & Industrial Ingredients–U.S./CAN, reliability at our Argo plant improved, with sequentially better production rates, and yields achieved throughout the quarter. We are pleased to say that the plant is operating at normal production rates across all major operating units. Looking ahead, we are focused on continued operational execution across our Food & Industrial Ingredients businesses and accelerating the growth of our Texture & Healthful Solutions portfolio. We have also commenced the integration planning work for the pending acquisition of Tate & Lyle, which, when completed, will establish Ingredion as a more comprehensive global leader in ingredient solutions with the innovation expertise and geographic reach that will help create the future of food.
Informational and educational content only. Not investment advice.